However, a relatively large proportion of high-Survivin-expressing rectal tumors (28/43; 65%) was found in our cohort although in the literature MMR-deficient tumors in the rectum are described less frequently (de Rosa et al. 2016). Here, BIRC5 is linked to rectal neoplasm.